Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offering $8 per share in cash. WidePoint gained 24.58% after an update on a major Department of Homeland Security contract award. These moves highlight investor optimism tied to revenue growth, acquisition activity, and government contracts in the biotech and tech sectors.
The stock moves of Iovance, SoundThinking, and WidePoint provide context for market activity. For readers following the health sector, here is Pluang's market snapshot as of Sep 30, 2026 04:11 WIB: Of 100 priced Health-sector US stocks tradable on Pluang, 42 rose and 56 fell today. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) up 14.44%, RXRX (Recursion Pharmaceuticals Inc) up 8.51%, and WGS (GeneDx Holdings Corp) down 11.58%.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
AST SpaceMobile's Chief Operating Officer sold 12,000 shares valued at $707,000 amid the company's stock rising 47% over the past year. This insider sale could indicate profit-taking after significant gains. Investors may watch for further insider ac...
